User banner image
User avatar
  • admin

Posts

139th Canton Fair Rolls Out Digital and Intelligent Upgrades to Elevate Buyer Experience

GUANGZHOU, China, March 26, 2026 /PRNewswire/ — Set to open soon on April 15 in Guangzhou, the 139th Canton Fair is launching a host of intelligent...

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Coty Inc. (COTY)

NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United...

Investview, Inc. Announces Rebrand of Subsidiary iGenius to Conectiv, Reflecting Strategic Expansion into Health, Wellness, and Lifestyle Offerings

Haverford, PA, March 25, 2026 (GLOBE NEWSWIRE) — Investview, Inc. (OTCQB: INVU), a diversified financial technology and consumer products company operating across multiple business units,...

Bronstein, Gewirtz & Grossman LLC Urges Coty Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Nationally Recognized Firm Urges Coty Investors to Explore Class Action Representation NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a...

AI Scale Detection Launches in Morpholio Trace

A New AI-Powered Feature Reads Scale Instantly, Automatically Detecting and Calibrating Drawings to Eliminate Setup Entirely. Columbia, MD, March 25, 2026 (GLOBE NEWSWIRE) — Morpholio from Vectorworks today...

Eat, Play, and Relax with Solo Excursions on Florida’s Historic Coast

As solo women-driven travel rises, St. Augustine, Ponte Vedra and The Beaches offers rich cultural experiences St. Augustine, FL, March 25, 2026 (GLOBE NEWSWIRE) —...

MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results

TORONTO, March 25, 2026 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”) a pharmaceutical company specialized in...

Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates

Product sales and commercial rights revenues in 2025 increased 90% year-over-year to US$82.1 million (RMB574.1 million) Sales of Olverembatinib increased 81% year-over-year to US$62.2 million (RMB435.3...

Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation

SARASOTA, Fla., March 25, 2026 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targeted therapeutics through proprietary intranasal delivery technology,...

XORTX Announces Share Consolidation

CALGARY, Alberta, March 25, 2026 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage...